SARS-CoV2 and Hyper-Inflammatory ARDS - The New Kid on the Block
In this third presentation of the five-part Updates on COVID-19 series, Dr. Ivan Rosas, M.D. discusses acute respiratory distress syndrome (ARDS), effective interventions, and ARDS phenotypes. He then relates ARDS research and guidelines to the current coronavirus pandemic and the clinical management of COVID-19. He concludes by introducing COVACTA, a new study focusing on potential pharmacological treatment of patients with severe COVID pneumonia.
Target Audience
This CME/CE activity is designed to meet the educational needs of physicians, residents, fellows, and community providers.
Faculty and trainees within the Department of Medicine who are involved in the care of patients need to be regularly updated with the recent advances and guidelines in the fields of internal medicine and quality improvement to increase clinical knowledge, and to implement the advances and guidelines in clinical practice to enhance the quality of patient care and outcomes.
Learning Objectives
At the conclusion of this activity, the participant should be able to:
Define phenotypes of adult respiratory distress syndrome (ARDS).
Discuss common features of COVID-19 and hyperimmune ARDS.
Review ARDS immune modulator clinical trials.
Describe a potential role for IL-6 blockade for COVID-19.
Richard J. Hamill, M.D., Planning Committee Member
Professor
Department of Medicine
Baylor College of Medicine
Houston, Texas
Disclosure: Nothing to disclose.
Erica Lescinskas, M.D., Planning Committee Member
Assistant Professor
Department of Medicine
Baylor College of Medicine
Houston, Texas
Disclosure: Nothing to disclose.
Zaven Sargsyan, M.D., Planning Committee Member
Assistant Professor
Department of Medicine
Baylor College of Medicine
Houston, Texas
Disclosure: Nothing to disclose.
Chirayu Shah, M.D., M.Ed., Planning Committee Member
Associate Professor
Department of Medicine
Baylor College of Medicine
Houston, Texas
Disclosure: Nothing to disclose.
Stephanie Sherman, M.D., Planning Committee Member
Assistant Professor
Department of Medicine
Baylor College of Medicine
Houston, Texas
Disclosure: Nothing to disclose.
Jefferson Triozzi, M.D., Planning Committee Member
Internal Medicine Resident
Department of Medicine
Baylor College of Medicine
Houston, Texas
Disclosure: Nothing to disclose.
Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Baylor College of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation